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Dr. Eddinger has focused on an important contemporary aspect of the epidemiology of infective 
endocarditis (IE), which has become a marker of the ongoing opioid epidemic in the United 
States. As evidenced in 'U(GGLQJHU¶V local experience, persons who inject drugs (PWID) now 
constitute an increasing proportion of patients who develop IE (1,2) and the human and 
healthcare costs related to such have been unprecedented. 
An analysis of PWID within the dataset described in our paper (3) would be of interest and we 
examined the possibility of doing this. Unfortunately, it is not possible for this to be done 
without new data abstraction and methodology. As Dr. Edinger points out, a further difficulty is 
that the ICD-9/10 coding system does not include codes for injection drug use. One is reliant on 
surrogate markers such as hepatitis C infection (not specific for PWID) or drug dependency/use 
codes that do not distinguish between injection and non-injection dependency/use. To address 
this, researchers have implemented different coding algorithms to detect PWID. However, in a 
study that used two such algorithms, there was a nearly 5-fold difference in the number of 
PWID-associated IE cases identified (1), highlighting the risk of misclassifying cases using 
current coding systems. 
The disparity in PWID representation in different sectors of the healthcare system, and hence 
different data sources, is also a problem. A recent North Carolina study (2) found different 
PWID-associated IE rates between different health insurance payers: Private (12%), Medicare 
(17%), Medicaid (35%), Self-pay/uninsured (34%), Other/unknown (3%).  Since our data only 
included Private and Medicare-related data, it is likely the impact of PWID-associated IE would 
have been smaller than had we also included Medicaid and self-pay/uninsured data. Indeed, 
because we quantified changes in antibiotic prophylaxis prescribing between 2000-2015, we 
were unable to use Medicaid data (see Methods section) because of a large age-distribution 
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change in enrollees with Medicaid-covered prescription drug benefits, caused by the transfer of 
Medicaid patients who were Medicare eligible to Medicare Part D prescription drug coverage in 
January 2006 (see on-line figure 1c).(3)  We were unable, therefore, to include Medicaid data in 
our study. 
Current coding systems are frustrating, as they are inadequate to permit analysis of important 
healthcare questions like this. Hopefully, coding system changes will allow us to do so in the 
future.  
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